Screener
Repligen RGEN EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Repligen in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Repligen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323773
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income | $5,008 | $14,866 | $13,341 | $20,696 |
| Earnings per share: | ||||
| Basic | $0.09 | $0.26 | $0.24 | $0.37 |
| Diluted | $0.09 | $0.26 | $0.24 | $0.37 |
| Weighted average common shares outstanding: | ||||
| Basic | 56,418 | 56,234 | 56,387 | 56,179 |
| Diluted | 56,638 | 56,510 | 56,661 | 56,509 |
| Net income | $5,008 | $14,866 | $13,341 | $20,696 |
ITEM 1. Financial Statements
FAQ
- What is Repligen's EPS (diluted)?
- Repligen (RGEN) reported EPS (diluted) of $0.09 in Q2 2026.
- How has Repligen's EPS (diluted) changed year-over-year?
- Repligen's EPS (diluted) decreased by 65.4% year-over-year, from $0.26 to $0.09.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Repligen's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude